Influence Positive End-expiratory Pressure on Autoregulation in Patients With Respiratory Insufficiency (dARICUPEEP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01376518|
Recruitment Status : Completed
First Posted : June 20, 2011
Last Update Posted : June 20, 2011
|Condition or disease||Intervention/treatment|
|Respiratory Insufficiency||Procedure: positive end-expiratory pressure|
|Study Type :||Observational|
|Actual Enrollment :||20 participants|
|Official Title:||Influence of Positive End-expiratory Pressure on the Cerebrovascular Autoregulation in Patients With Respiratory Failure|
|Study Start Date :||January 2011|
|Primary Completion Date :||June 2011|
|Study Completion Date :||June 2011|
patients with respiratory failure and need of high positive end-expiratory pressure ventilation.
Procedure: positive end-expiratory pressure
Elevation of positive end-expiratory failure for recruitment
Other Name: PEEP
- Change from Baseline cerebrovascular autoregulation due to elevated positive end-expiratory pressure [ Time Frame: 1 Year ]Is there an impairment of cerebrovascular autoregulation due to positive end-expiratory pressure ventilation this will be a major side effect especial in patients with brain injury.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01376518
|University medical centre|
|Mainz, Germany, 55131|
|Principal Investigator:||Patrick Schramm, MD||Department of Anesthesiology, University medicine Mainz, Germany|